Skip to main content
. 2022 Sep 30;2022:5811219. doi: 10.1155/2022/5811219

Table 2.

Comparison of effective rate and OS time in patients with advanced NSCLC (n, %).

Factor Cases (n = 175) Efficacy of chemotherapy χ 2 value P value Median OS time (month) χ 2 Value P value
Gender
Male 115 53 (46.1) 0.029 0.865 15.3 2.518 0.113
Female 60 29 (48.3) 14.9

Age (Years old)
<65 71 36 (50.7) 0.255 0.614 15.2 0.513 0.474
≥65 104 46 (44.2) 16.9

Smoking status
Yes 98 42 (42.9) 0.515 0.473 14.9 0.462 0.497
No 77 40 (43.5) 15.3

PS score (points)
0∼1 123 55 (44.7) 0.336 0.623 16.4 3.558 0.060
≥2 52 27 (51.9) 14.5

Pathological type
Squamous cell carcinoma 94 45 (47.9) 0.961 0.327 15.8 0.093 0.761
Adenocarcinoma 71 33 (44.0) 15.2
Large cell carcinoma 10 4 (40.0) 15.0

TNM staging
IIIb 106 63 (59.4) 6.555 0.010 15.9 0.834 0.361
IV 69 19 (27.5) 14.8

PLR level
<197 78 48 (61.5) 6.937 0.037 20.8 3.393 0.047
≥197 97 34 (35.0) 12.0